Ova ukazhuva na vlijanie na drugi faktori (od domakji-not ili bakterijata) vo razvojot na nevroloshkite simptomi poinfektsija so C.jejuni [2].Serumi od patsienti so GBS nastanat po infektsija so C.jejuni, poka-zhuvaat pozitivna reaktivnost so flagelaren protein (63 kDa) izo-liran od C.jejuni serotip O:19 i so Gal(b1-3)GalNAc-vrzuvachkiglikoproteini izolirani od khuman periferen nerv [3,4]. Ovie po-datotsi ukazhuvaat na mozhnosta za postoenje na molekularna mimi-krija na glikoproteini prisutni vo C. jejuni i glikoproteiniprisutni vo khumanite periferni nervi i na nejzinata potentsijal-na uloga vo razvojot na nevropatiite.Tselta na ovoj trud beshe da se karakterizaat glikoproteinite pri-sutni vo khuman periferen nerv i vo C.jejuni (O:19), izoliran od pa-tsienti so nekomplitsiran enteritis i od patsienti so enteritispropraten so GBS. Za taa tsel beshe ispitana reaktivnosta navkupnite proteinski ekstrakti od khuman periferen nerv i od dvatabakteriski izolati so aglutinin od kikiriki (peanut agglutinin -PNA) kako marker za Gal (b1-3) GalNAc determinantata i so serumiod patsienti so GBS.EKSPERIMENTAlEN DElIzolatsija na proteini od khuman periferen nervKhumaniot periferen nerv e dobien postmortalno, 8 chasa po smrt napatsient koj pochinal od ne-nevroloshka bolest i se chuva zamrznat na -70 degC. (Institut za sudska meditsina, Meditsinski fakultet,Univerzitet ,,Sv.Kiril i Metodij", Skopje, R. Makedonija). Izolatsijatana glikoproteinite beshe izvrshena spored propisot na Apostolski etal., 1994 [4]. Dobienite izolati se chuvani na - 20degC, do upotreba.Izolatsija na proteini od C.jejuni serotip O:19 (GBS i enteritisasotsiran)C.jejuni serotip O:19, GBS asotsiran, e dobien od ATCC 700297.C.jejuni serotip O:19, enteritis asotsiran, e dobien od Institutotza mikrobiologija i parazitologija, Meditsinski fakultet, Univer-zitet ,,Sv. Kiril i Metodij", Skopje, R. Makedonija. Kulturite serasteni na 37deg vo Campylobacter agar, 48 chasa vo mikroaerofilniuslovi. Proteinite se ekstrakhirani od bakteriskite kletki soprimena na metodot opishan od Liu X, et al., 2006 [5].Odreduvanje na kontsentratsija na izoliranite proteiniKontsentratsijata na proteinite (mg/ml) e opredelena so primenana metodot na Bradford [6]. Kalibratsionata kriva (absorbantsija/kontsentratsija) e dobiena od standardni rastvori na govedski se-rum albumin (BSA) vo opseg od 0,2 - 3 mg/ml.Western blot analizaIzoliranite glikoproini po separatsija na SDS/PAGE elektro-foreza (10 % acrylamid/bisacrylamid gel) [7] (10 mg/bunarche,) i tran-sfer na nitrotselulozna membrana, se analizirani na western blotso inkubatsija so biotiniliran PNA (10 mg/ml) i serumi od 6patsienti so GBS (1:100).REzUlTATI I DISKUSIJAKontsetratsiite na proteinite vo izolatite od khuman periferennerv i od bakteriite, opredeleni so metodot na Bradford, se da-deni vo Tabela 1.Tabela 1. Kontsentratsija na izoliranite proteiniProteinjnski izolati od: Kontsentratsija (ug/ul) Khuman periferennerv 1,8 ug/ul C.jejuni O:19 enteritis 1,6 ug/ul C.jejuni O:19 GBS0,5 ug/ul Boenjeto na separiranite glikoproteini so PNA ukazhuvana prisustvo na GalGalNAc determinantata vo nekolku proteini vosite tri ekstrakti (Slika 1).Slika 1. Western blot analiza na glikoproteini od khumanperiferen nerv (1), C.jejuni GBS asotsiran (2) and C.jejuni enteritisasotsiran (3) boeni so biotiniliran PNA.Western blot analizata na reaktivnosta na izoliranite glikopro-teini so serumi od patsienti so GBS, pokazha pozitivna reaktivnostna eden glaven protein so molekulska masa okolu 60 kDa, i nekolkudrugi proteini so pomala molekulska masa, vo site tri proteinskiekstrakti (Slika 2). Reaktivnosta e pointenzivna vo izolatot odC.jejuni (O:19) GBS asotsiran, vo odnos na izolatot od C.jejuni (O:19)enteritis asotsiran.Slika 2. Western blot analiza na glikoproteini od khuman perife-ren nerv (1), C.jejuni GBS asotsiran (2) and C.jejuni enteritis asotsi-ran (3) inkubirani so serum od GBS.322PETTI KONGRES NA FARMATsIJATA SO MEGjUNARODNO UChESTVOMakedonski farmatsevtski bilten 57 (dodatok), 2011KLINIChKA FARMATsIJA oralni prezentatsiizAKlUChOKVo proteinskite ekstrakti dobieni od khuman periferen nerv i oddvata izolati na C.jejuni (O:19): enteritis i GBS asotsirani, po-tvrdeno e prisustvoto na GalGalNAc determinantata kaj nekolkuproteini i istite vkrsteno reagiraat so serumi od patsienti soGBS. Ovaa vkrstena reaktivnost ja poddrzhuva khipotezata za mole-kularna mimikrija pomegju khumanite i bakteriskite proteinskistrukturi.Potrebni se ponatamoshni ispituvanja za rasvetluvanje na moleku-larnata struktura na vkrsteno-reaktivnite glikoproteini i nivna-ta potentsijalna uloga vo avtoimunite nevropatii.lITERATURA1.Wirguin I, Suturkova-Milosevic Lj, Della-Latta P, Fisher T, Brown RH Jr, Latov N (1994),Ann. Neurol., 35: 698-7032.Ang CW, Laman JD, Willison HJ, Wagner ER, Endtz HP, De Klerk MA, Tio-Gillen AP, Vanden Braak N, Jacobs BC, Van Doorn PA (2002), Infect. Immun., 70: 1202-12083.Lange D, Aleksic S, Kassubek J, Vrvic MM, Kist M, Steinbruckner B, Mitova M (1999),Zent. Bl. Bakteriol., 289: 429-4444. Apostolski S, Sadiq SA, Hays A, Corbo M, Suturkova-Mislosevic Lj, Chaliff P, Ste-fansson K, LeBaron RG, Ruoslahti E, Hays AP, Latov N. (1994) J Neurosci Res; 38:134-1415. Liu X, McNally DJ, Nothaft H, Szymanski CM, Brisson JR, Li J. (2006) Anal. Chem. ; 78:6081-6087.6. Bradford M.M. (1976) Anal.Biochem., 72, 148-2547. Laemmli (1970) U.K. Nature, 227: 680-685InductIon of antI-ganglIosIdeantIbodIes In guIllaIn-barresyndrome anImal modelGrozdanova Aleksandra1, Poceva Panovska Ana1,Brezovska Katerina1, Trajkovska-Dokic Elena2,Apostolski Slobodan3, Suturkova Ljubica11 Institute for Pharmaceutical chemistry, Faculty of Pharmacy, "St Cyriland Methodius" University, Skopje2 Institute of Microbiology and parasitology, Medical faculty, "St Cyriland Methodius" University Skopje3 Outpatient Neurological Clinic, Belgrade, SebiaIntroductIonExperimental evidence obtained from human and animal studiessupport the hypothesis that carbohydrate mimicry betweenlipopolysaccharides (LPSs) from certain Campylobacter jejuniserotypes and human neural gangliosides can result in production ofantiganglioside antibodies which play a key role in pathogenesisGuillain-Barre syndrome (GBS).Latest data showed that one third of GBS patients had conferred an-tecedent C. jejuni infection, and that specific C. jejuni serotypes areassociated with development of GBS. C. jejuni serotype O:19 is mostcommonly associated with GBS, and reports showed association alsowith O:2, O:15, O:18, O:24, O:30, O:37 and O:53 serotypes. Animalmodels used to reproduce GBS can be achieved by infection or byimmunization with the infection agent or purified antigens in order toinduce cross-reactive immune response, clinical symptoms or toinvestigate other aspects of proposed molecular mimicry.aImThe aim of the present study was to investigate whether immunizationof rabbits with LPSs of different C. jejuni serotypes isolated from un-complicated enteritis patients can induce anti-ganglioside and anti-LPS antibodies. The development of pathophysiological features inimmunized animals was investigated.materIal and methodsNew Zeland white rabbits were immunized with LPSs C. jejuniserotypes 0:3, 0:19, 0:27, 0:37 isolated from enteritis patients and withC. jejuni LPS 0:19 (ATCC 700297) reference strain from GBS patient. Inthe structure of LPSs used for immunization we conferred the pres-ence of cross-reactive ganglioside-like epitopes through binding stud-ies with cholera toxin B subunit and peanut agglutinin, with exceptionof serotype 0:3 known not to contain a ganglioside like structure andwhich was used as control. We used complete Freund's adjuvant (CFA)and keyhole-limpet hemocyanine (KLH) as adjuvants.resultsThe animals were tested every 2 weeks in period of 6 mounths for IgGand IgM anti-ganglioside (GM1 and AG1) and anti-LPS antibodies usingELISA. The stool cultures for C. jejuni were all negative, indicating thatthe rise in antibodies had been induced by the immunization and notby a concurrent infection with C. jejuni. Furthermore, antigangliosideand anti-LPS reactivity could not be detected in preimmune serumsamples. Neither anti-LPS nor anti-ganglioside response was seen inthe adjuvant controls. In general all rabbits immunized with LPSs re-sponded with the production of IgM and IgG anti-LPS antibodies thatcould be detected a few weeks before anti-ganglioside responses. El-evated titers of IgM antibodies to LPS could be detected 14 days afterthe first injection while IgG responses to LPS were present after 28days and continued to rise during the immunization period.Rabbits that were immunized with LPS O:19 GBS associated seros-train (ATCC 700297) had higest IgM and IgG anti-GM1 antibodies, andhigh anti-GA1 IgG. Strong IgG and IgM GM1 antibody response was de-tected in animals immunized with LPS O:19 enteritis isolate, withmodes induction of IgG anti-GA1. Serotypes 0:27 and 0:37 from en-teritis patients induce rise in the IgG anti-GA1 antibody, but low levelof anti-GM1 antibody were detected.Immunization with LPS from the O:3 serostrain, which does not bearganglioside structure, only resulted in a strong anti-LPS response, withno reactivity against any of the gangliosides.conclusIonsThe animals did not develop any neurological signs during the 6-monthfollow-up period, but loss of weight, partial weakness and absence of re-activity were present in animal. The sera from immunized animal withhigh GM1 and AG1 antibody reacted with isolated LPSs structures fromC. jejuni enteritis patients, indicating that carbohydrate mimicry betweengangliosides and the C. jejuni LPS induces the production of cross-reac-tive autoantibodies and probably trigerss the development of GBS.referencesAng C.W., De Klerk M. A., Endtz H. P., Jacobs B.C., Laman J. D., Van der Meche F.G.A.and Van Doorn P.A., 2001. Guillain-Barre syndrome and Miller-Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1bantibodies in rabbits. Infect. Immun. 69: 2462-2469Ang C.W., Jacobs B.C., Laman J.D., 2004. The Guillain-Barre syndrome: a true case ofmolecular mimicry. Trends Immunol. 25:61-66.Ariga T. and Yu R. K., 2005. Anti-glycolipid antibodies in Guillain-Barre syndrome andrelated diseases: review of clinical features and antibody specificities. J. Neurosci.Res. 80:1-17.323fIfth congress of pharmacy of macedonIa WIth InternatIonal partIcIpatIonMacedonian Pharmaceutical Bulletin 57 (suppl), 2011CLINICAL PHARMACY oral presentationsAspinall G.O., McDonald A.G., Raju T.S., Pang H., Moran A.P. and Penner J.L., 1993.Chemical structures of the core regions of Campylobacter jejuni serotypes O:1, O:4,O:23, and O:36 lipopolysaccharides. Eur. J. Biochem. 213:1017-1027.Grozdanova A., Poceva A., Brezovska K., Trajkovska-Dokic E., Apostolski S. andSuturkova Lj., 2011. Cross-reactive epitopes in Campylobacter jejuni strains isolatedfrom enteritis patients, Prilozi MASA, june 2011 (in press)Hughes R.A. 1999. Pathogenesis of Guillain-Barre' syndrome. J. Neuroimmunol. 100,74-97Hughes R.A. 2005. Multidisciplinary Consensus Group. Supportive care for patientswith Guillain-Barre syndrome. Arch., Neurol. 62: 1194-1198.Hughes R.A., Swan A. V., Raphal J., Annane D. and Van Doorn P.A. 2007.Immunotherapy for Guillain-Barree syndrome: a systematic review Brain, vol. 130,2245-2257Illa I., Ortiz N., Gallard E., Juarez C., Grau J.M. and Dalakas M.C. 1995. Acute axonalGuillain-Barresyndrome with IgG antibodies against motor axons following parenteralgangliosides. Ann Neurol; 38:218-24.Ilyas A.A., Willison H.J., Quarles R.H., Jungalwala F.B., Cornblath D.R., Trapp B.D.,Griffin D.E., Griffin J.W. and McKhann G.M. 1988. Serum antibodies to gangliosides inGuillain-Barre syndrome. Ann Neurol 23:440-447Nachamkin I. 2001. Campylobacter Enteritis and the Guillain-Barre Syndrome. CurrInfect Dis Rep 3, 116-122.Plomp J.J. et al. 1999, Miller Fisher anti-GQ1b antibodies: a-latrotoxin-like effects onmotor endplates. Ann. Neurol. 45, 189-199Rees J.H., Soudain S.E., Gregson N.A.